West Virginia legislation · 2026 Regular Session
West Virginia HB5553: Relating to participation in federal prescription drug pricing programs.
Status: Introduced, February 16, 2026
Sponsors
- Holstein, Josh (R, 032) · primary sponsor
- J., Cannon, (I)
- Daniel Linville (R)
- Rohrbach, Matthew (R, 026)
- Funkhouser, Joe (R, 098)
Latest actions
- : To House Health and Human Resources
- : Introduced in House
- : To Health and Human Resources
- : Filed for introduction
Subjects: Date Introduced, Bill Tracking », Floor Activity, Roll Call Votes, Short Title, Committee Activity, Sponsor, All Same As
Common questions
- What is HB5553?
- HB5553 is a bill in the West Virginia Legislature (2026 Regular Session): Relating to participation in federal prescription drug pricing programs.
- What is the status of HB5553?
- Introduced as of February 16, 2026. Latest action: To House Health and Human Resources (February 16, 2026).
- Who sponsored HB5553?
- Holstein, Josh (R, 032), with 4 co-sponsors.
- Where is the official record for HB5553?
- On the West Virginia Legislature website: https://www.wvlegislature.gov/bill_status/Bills_history.cfm?input=5553&year=2026&sessiontype=RS&btype=bill
Source: official West Virginia record. Tracked by Delilah, AI for legislation across all 50 states and Congress.